Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

4.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.2K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

3.1K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.1K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

4.8K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.8K
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

13.7K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
13.7K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

2.0K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.0K
Genetic Variation01:25

Genetic Variation

1.2K
Genetic variation is the diversity in DNA sequences found among individuals of the same species. This diversity is crucial for a species' survival because it helps organisms adapt to environmental changes. Genetic variation begins with fertilization, where an egg and sperm cell merge. Each of these cells carries 23 chromosomes, up to 46 in the fertilized egg. Chromosomes are long DNA strands that contain genes, the basic units of heredity.
Genes exist in different versions called alleles,...
1.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Secular Increase in the Incidence of Islet Autoimmunity Among Colorado Children With Moderate-Risk HLA Genotypes.

Diabetes care·2026
Same author

SARS-CoV-2 and diabetes: a post-pandemic reappraisal.

Diabetologia·2026
Same author

Extended Follow-up of Type 1 Diabetes Immunotherapy Trial Participants Suggests Benign Side Effect Profile.

Diabetes care·2026
Same author

Counting fluorescent emitters with a single photon avalanche diode array.

bioRxiv : the preprint server for biology·2026
Same author

Diurnal Variation of Islet Autoantibody Titers in Established Type 1 Diabetes Suggests Restricted-Time Sampling Improves Aab Measurement and Detection.

Research square·2026
Same author

New and emerging therapies in type 1 diabetes mellitus.

The Journal of clinical investigation·2026

Related Experiment Video

Updated: Jan 9, 2026

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells
06:27

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells

Published on: May 6, 2013

17.2K

Type 2 Diabetes Genetic Risk and Type 1 Diabetes Heterogeneity and Progression.

Taylor M Triolo1, Jay M Sosenko2, David Cuthbertson3

  • 1Barbara Davis Center for Diabetes, University of Colorado Anschutz Medical Campus, Aurora, CO.

Diabetes
|December 10, 2025
PubMed
Summary
This summary is machine-generated.

Genetic predisposition to type 2 diabetes influences insulin secretion and speeds up type 1 diabetes progression in at-risk individuals. Understanding these type 2 diabetes mechanisms can improve type 1 diabetes prediction and prevention strategies.

More Related Videos

Generation of High Quality Chromatin Immunoprecipitation DNA Template for High-throughput Sequencing ChIP-seq
09:52

Generation of High Quality Chromatin Immunoprecipitation DNA Template for High-throughput Sequencing ChIP-seq

Published on: April 19, 2013

24.8K
A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
06:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

3.1K

Related Experiment Videos

Last Updated: Jan 9, 2026

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells
06:27

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells

Published on: May 6, 2013

17.2K
Generation of High Quality Chromatin Immunoprecipitation DNA Template for High-throughput Sequencing ChIP-seq
09:52

Generation of High Quality Chromatin Immunoprecipitation DNA Template for High-throughput Sequencing ChIP-seq

Published on: April 19, 2013

24.8K
A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
06:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

3.1K

Area of Science:

  • Endocrinology
  • Genetics
  • Metabolic Disease

Background:

  • Insulin secretion variability in preclinical type 1 diabetes (T1D) presents challenges for precision medicine.
  • Genetic factors influencing β-cell function and disease progression in T1D require further investigation.

Purpose of the Study:

  • To determine if genetic predisposition to type 2 diabetes (T2D), measured by a T2D genetic risk score (T2D-GRS), affects β-cell function and T1D progression in individuals at risk for T1D.
  • To explore the interplay between T2D-GRS, T1D genetic risk score 2 (T1D-GRS2), and metabolic heterogeneity in preclinical T1D.

Main Methods:

  • Analysis of 4,324 autoantibody-positive participants from the TrialNet Pathway to Prevention study.
  • Genome-wide genotyping and oral glucose tolerance testing (OGTT) to assess insulin secretion (C-peptide area under the curve [AUC]).
  • Statistical analysis to correlate T2D-GRS and T1D-GRS2 with clinical and metabolic parameters.

Main Results:

  • Significant differences in T2D-GRS and T1D-GRS2 were observed across groups with varying C-peptide AUC.
  • Individuals with higher C-peptide AUC exhibited higher T2D-GRS, lower T1D-GRS2, increased insulin resistance, and other distinct clinical features.
  • Progression to clinical T1D was associated with T1D-GRS2 and, in most groups, with T2D-GRS.

Conclusions:

  • Genetic burden for T2D significantly shapes metabolic heterogeneity and accelerates T1D progression in the preclinical stage.
  • Investigating T2D-related mechanisms offers potential avenues for improving T1D prediction and prevention strategies.